Histopathology and Electron Microscopy Evaluation of the Sildenafil Effect on Diabetic Rats' Retinae

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2023 Dec 22

PMID 38131552

Authors

Dina Tadros

Tamer I Abdelhalim

Naglaa Sarhan

Noha El-Anwar

Reem A Elkholy

Dina Tahoon

Osama A Sorour

Affiliations

Soon will be listed here.

Abstract

Purpose: Although there is increasing evidence that phosphodiesterase-5 (PDE-5) inhibitors modify the effect of diabetes on different tissues, its effect on diabetic retinopathy is not well studied.

Methods: Forty male Sprague-Dawley (SD) rats were divided into four groups: group I = control group that received no treatment; group II (diabetic group), in which diabetes was induced by a single streptozotocin injection; group III (sildenafil small dose, SSD), in which diabetes was similarly introduced (however, rats received daily oral 1 mg/kg sildenafil citrate (SC) for 3 months); and group IV (sildenafil large dose, SLD), which was as in group 3, but SC was 2.5 mg/kg. After 3 months, globes were removed and retinae were dissected; one globe from each rat was examined by light microscopy (LM), and the other by electron microscopy (EM).

Results: In contrast to the control group, diabetic rats in group II demonstrated well-established diabetic changes in the form of capillary congestion, decreased cell population, hyaline changes of capillary walls, and degenerated nerve fiber layer by LM. Similarly, EM demonstrated photoreceptor degeneration, mitochondrial cristolysis, and vacuolated depleted cells among other features in group II. These diabetic features were less prominent in group III and nearly absent in group IV.

Conclusion: SC use in the early stages of DR may prevent/delay diabetic retinopathy development or progression in diabetic rat models, an effect that seems to be dose-related.

References

Haefliger I, Flammer J, Luscher T . Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992; 33(7):2340-3. View

Burnett A, Strong T, Trock B, Jin L, Bivalacqua T, Musicki B . Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol. 2008; 181(1):245-51. DOI: 10.1016/j.juro.2008.09.005. View

Mostafa T, Rashed L, Kotb K, Taymour M . Effect of testosterone and frequent low-dose sildenafil/tadalafil on cavernous tissue oxidative stress of aged diabetic rats. Andrologia. 2012; 44(6):411-5. DOI: 10.1111/j.1439-0272.2012.01294.x. View

Di Luigi L, Corinaldesi C, Colletti M, Scolletta S, Antinozzi C, Vannelli G . Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation. 2016; 39(3):1238-52. PMC: 4883282. DOI: 10.1007/s10753-016-0359-6. View

Gui F, You Z, Fu S, Wu H, Zhang Y . Endothelial Dysfunction in Diabetic Retinopathy. Front Endocrinol (Lausanne). 2020; 11:591. PMC: 7499433. DOI: 10.3389/fendo.2020.00591. View

Jayadev C, Ramasastry P, Gul A, Vinekar A . Possible Role of Sildenafil Citrate in the Recurrence of Neovascularization in Laser-regressed Aggressive Posterior ROP. Indian Pediatr. 2016; 53 Suppl 2:S155-S156. View

Korhonen A, Gucciardo E, Lehti K, Loukovaara S . Phosphodiesterase type 5 inhibitor (sildenafil) - impact in proliferative diabetic retinopathy?. Acta Ophthalmol. 2021; 100(5):e1187-e1188. DOI: 10.1111/aos.15058. View

Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R . A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Arterioscler Thromb Vasc Biol. 2010; 30(7):1315-24. DOI: 10.1161/ATVBAHA.109.201327. View

Zahran M, Hussein A, Barakat N, Awadalla A, Khater S, Harraz A . Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injury. Int Urol Nephrol. 2015; 47(11):1907-15. DOI: 10.1007/s11255-015-1099-5. View

10.

Sorour O, Liu K, Mehta N, Braun P, Gendelman I, Nassar E . Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema. Int J Retina Vitreous. 2020; 6:17. PMC: 7278067. DOI: 10.1186/s40942-020-00220-5. View

11.

Baron-Menguy C, Bocquet A, Richard A, Guihot A, Toutain B, Pacaud P . Sildenafil-Induced Revascularization of Rat Hindlimb Involves Arteriogenesis through PI3K/AKT and eNOS Activation. Int J Mol Sci. 2022; 23(10). PMC: 9143320. DOI: 10.3390/ijms23105542. View

12.

Luo L, Dai D, Cheng Y, Zhang Q, Yuan W, Dai Y . Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats. J Pharm Pharmacol. 2011; 63(7):943-51. DOI: 10.1111/j.2042-7158.2011.01268.x. View

13.

Zanoni D, Da Silva G, Ezra-Elia R, Carvalho M, Quitzan J, Ofri R . Histological, morphometric, protein and gene expression analyses of rat retinas with ischaemia-reperfusion injury model treated with sildenafil citrate. Int J Exp Pathol. 2017; 98(3):147-157. PMC: 5573770. DOI: 10.1111/iep.12233. View

14.

Wang L, Chopp M, Szalad A, Jia L, Lu X, Lu M . Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice. PLoS One. 2015; 10(2):e0118134. PMC: 4331563. DOI: 10.1371/journal.pone.0118134. View

15.

Kurtulan E, Gulcu A, Secil M, Celebi I, Aslan G, Esen A . Effects of sildenafil on ocular perfusion demonstrated by color Doppler ultrasonography. Int J Impot Res. 2004; 16(3):244-8. DOI: 10.1038/sj.ijir.3901189. View

16.

Burton A, Reynolds A, ONeill D . Sildenafil (Viagra) a cause of proliferative diabetic retinopathy?. Eye (Lond). 2000; 14 Pt 5:785-6. DOI: 10.1038/eye.2000.205. View

17.

Vobig M, Klotz T, Staak M, Bartz-Schmidt K, Engelmann U, Walter P . Retinal side-effects of sildenafil. Lancet. 1999; 353(9150):375. DOI: 10.1016/s0140-6736(98)05473-7. View

18.

Harris A, Kagemann L, Ehrlich R, Ehrlich Y, Lopez C, Purvin V . The effect of sildenafil on ocular blood flow. Br J Ophthalmol. 2008; 92(4):469-73. DOI: 10.1136/bjo.2007.131789. View

19.

Saberi Firouzi S, Sarvestani N, Bakhtiarian A, Ghazi Khansari M, Karimi M, Ranjbar A . Sildenafil protective effects on high glucose-induced neurotoxicity in PC12 cells: the role of oxidative stress, apoptosis, and inflammation pathways in an in vitro cellular model for diabetic neuropathy. Neurol Res. 2018; 40(8):624-636. DOI: 10.1080/01616412.2018.1458813. View

20.

Jung S, Johnstone A, Khoja Z, Rampakakis E, Lachapelle P, Wintermark P . Sildenafil Improves Functional and Structural Outcome of Retinal Injury Following Term Neonatal Hypoxia-Ischemia. Invest Ophthalmol Vis Sci. 2016; 57(10):4306-14. DOI: 10.1167/iovs.16-19385. View